These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
406 related items for PubMed ID: 31350093
21. An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23. Song D, Guan W, Coon LM, Al-Kali A, Oliveira JL, Lee FS. Hypoxia (Auckl); 2019; 7():81-86. PubMed ID: 31853455 [Abstract] [Full Text] [Related]
22. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Wiesener MS, Seyfarth M, Warnecke C, Jürgensen JS, Rosenberger C, Morgan NV, Maher ER, Frei U, Eckardt KU. Blood; 2002 May 15; 99(10):3562-5. PubMed ID: 11986208 [Abstract] [Full Text] [Related]
23. Inactivation of HIF-prolyl 4-hydroxylases 1, 2 and 3 in NG2-expressing cells induces HIF2-mediated neurovascular expansion independent of erythropoietin. Urrutia AA, Guan N, Mesa-Ciller C, Afzal A, Davidoff O, Haase VH. Acta Physiol (Oxf); 2021 Jan 15; 231(1):e13547. PubMed ID: 32846048 [Abstract] [Full Text] [Related]
25. Mutations in the VHL gene in sporadic apparently congenital polycythemia. Pastore YD, Jelinek J, Ang S, Guan Y, Liu E, Jedlickova K, Krishnamurti L, Prchal JT. Blood; 2003 Feb 15; 101(4):1591-5. PubMed ID: 12393546 [Abstract] [Full Text] [Related]
26. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia. Frey H, Moreth K, Hsieh LT, Zeng-Brouwers J, Rathkolb B, Fuchs H, Gailus-Durner V, Iozzo RV, de Angelis MH, Schaefer L. Glycoconj J; 2017 Jun 15; 34(3):393-404. PubMed ID: 27600268 [Abstract] [Full Text] [Related]
27. Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene. Al-Sheikh M, Moradkhani K, Lopez M, Wajcman H, Préhu C. Blood Cells Mol Dis; 2008 Jun 15; 40(2):160-5. PubMed ID: 17933562 [Abstract] [Full Text] [Related]
28. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis. Franke K, Kalucka J, Mamlouk S, Singh RP, Muschter A, Weidemann A, Iyengar V, Jahn S, Wieczorek K, Geiger K, Muders M, Sykes AM, Poitz DM, Ripich T, Otto T, Bergmann S, Breier G, Baretton G, Fong GH, Greaves DR, Bornstein S, Chavakis T, Fandrey J, Gassmann M, Wielockx B. Blood; 2013 Feb 21; 121(8):1436-45. PubMed ID: 23264599 [Abstract] [Full Text] [Related]
29. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia. Ladroue C, Hoogewijs D, Gad S, Carcenac R, Storti F, Barrois M, Gimenez-Roqueplo AP, Leporrier M, Casadevall N, Hermine O, Kiladjian JJ, Baruchel A, Fakhoury F, Bressac-de Paillerets B, Feunteun J, Mazure N, Pouysségur J, Wenger RH, Richard S, Gardie B. Haematologica; 2012 Jan 21; 97(1):9-14. PubMed ID: 21933857 [Abstract] [Full Text] [Related]
30. Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice. Li X, Sutherland S, Takeda K, Fong GH, Lee FS. Blood Cells Mol Dis; 2010 Jun 15; 45(1):9-19. PubMed ID: 20400342 [Abstract] [Full Text] [Related]
31. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS, Simon MC, Keith B, Haase VH. J Clin Invest; 2007 Apr 15; 117(4):1068-77. PubMed ID: 17404621 [Abstract] [Full Text] [Related]
33. A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case report. Pang Y, Gupta G, Yang C, Wang H, Huynh TT, Abdullaev Z, Pack SD, Percy MJ, Lappin TRJ, Zhuang Z, Pacak K. BMC Cancer; 2018 Mar 13; 18(1):286. PubMed ID: 29534684 [Abstract] [Full Text] [Related]
34. Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression. Sun W, Kosyna FK, Jelkmann W, Depping R. Cell Physiol Biochem; 2015 Mar 13; 37(6):2257-64. PubMed ID: 26624507 [Abstract] [Full Text] [Related]
35. Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases. Ghosh MC, Zhang DL, Ollivierre WH, Noguchi A, Springer DA, Linehan WM, Rouault TA. Blood; 2021 May 06; 137(18):2509-2519. PubMed ID: 33512384 [Abstract] [Full Text] [Related]
36. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia. Yang C, Zhuang Z, Fliedner SM, Shankavaram U, Sun MG, Bullova P, Zhu R, Elkahloun AG, Kourlas PJ, Merino M, Kebebew E, Pacak K. J Mol Med (Berl); 2015 Jan 06; 93(1):93-104. PubMed ID: 25263965 [Abstract] [Full Text] [Related]
37. "Benign erythrocytosis" and other familial and congenital polycythemias. Prchal JT, Sokol L. Eur J Haematol; 1996 Oct 06; 57(4):263-8. PubMed ID: 8982288 [Abstract] [Full Text] [Related]
38. Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells. Rauner M, Franke K, Murray M, Singh RP, Hiram-Bab S, Platzbecker U, Gassmann M, Socolovsky M, Neumann D, Gabet Y, Chavakis T, Hofbauer LC, Wielockx B. J Bone Miner Res; 2016 Oct 06; 31(10):1877-1887. PubMed ID: 27082941 [Abstract] [Full Text] [Related]